Estrella Immunopharma (ESLA) Assets (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Assets of $3.7 million for Q1 2026, up 49.62% year-over-year from $2.4 million in Q1 2025, and up 15.12% quarter-over-quarter from $3.2 million in Q4 2025.
Estrella Immunopharma (ESLA) Assets (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Assets for 6 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 49.62% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $3.7 million (up 49.62% YoY), while the FY2025 annual figure was $3.2 million, up 1.15% from the prior year.
- Assets advanced to $3.7 million in Q1 2026 per ESLA's latest filing, from $3.2 million in the prior quarter.
- Across five years, Assets topped out at $45.6 million in Q3 2022 and bottomed at $2.4 million in Q1 2025.
- Historically, Assets has averaged $13.6 million across 5 years, with a median of $4.5 million in 2024.
- Annual changes were most pronounced in 2023 — Assets tumbled 93.33% — and 2026, when it soared 49.62%.
- Estrella Immunopharma's Assets stood at $9.7 million in 2022, then dropped by 2.84% to $9.4 million in 2023, then sank by 66.75% to $3.1 million in 2024, then rose by 1.15% to $3.2 million in 2025, then increased by 15.12% to $3.7 million in 2026.
- Business Quant data shows ESLA's Assets at $3.7 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Estrella Immunopharma | 32.24 Mn | 32.10 Mn | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 2.98 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 8.63 Mn |
| Dec 31, 2023 | 9.45 Mn |
| Sep 30, 2023 | 27.35 Mn |
| Jun 30, 2023 | 3.03 Mn |
| Mar 31, 2023 | 9.78 Mn |
| Dec 31, 2022 | 9.72 Mn |
| Sep 30, 2022 | 45.62 Mn |
| Jun 30, 2022 | 45.38 Mn |
| Mar 31, 2022 | 45.62 Mn |
| Dec 31, 2021 | 45.80 Mn |
| Sep 30, 2021 | 45.97 Mn |